GUIDANCE DOCUMENT
FDA Records Access Authority for Cosmetic Products Draft Guidance for Industry January 2026
Not for implementation. Contains non-binding recommendations.
- Docket Number:
- FDA-2025-D-2243
- Issued by:
-
Guidance Issuing OfficeOffice of Inspections and Investigations
The purpose of this document is to provide guidance to industry on FDA's authority to access and copy records related to cosmetic products under sections 605, 610, and 704 of the Federal Food, Drug, and Cosmetic Act (the FD&C Act or the Act). The guidance in this document is in the form of Questions and Answers and provides answers to common questions that might arise about these records access provisions and FDA's current thinking regarding their implementation.
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2025-D-2243.